Natural Products Development

Download BioFlock Poultry ES KQ Sep 16

Download Proposal 1 Web

BioAust Health Pty Ltd has commenced a number of projects to deliver new science and technology to the Health, Cosmetic, Nutraceutical and Pharmaceutical industries.

These new technologies are a combination of development of new compounds from natural plant extracts linked to some very inventive nano-technology. The result will give a range of new products that will provide much longer life and greater efficacy in application.

The technologies are being developed both in Australia and overseas. The product groups are wide in diversity but each has a market calling for stronger natural product development and a wider level of innovation. The areas of development include household cleaning products, personal care products, insect repellency and control products, human health products, animal health products and

In China, BioAust has signed an agreement with a Botanical Refinery to develop new compounds for use in many product developments. The equipment in the refinery, not available in Australia, is state-of-the-art and will produce compounds that will be 99% pure (or better). These developments will link with our Seed Technology and Integrated Pest Management projects.

In Australia and Vietnam BioAust health has developed a natural feed additive that when used on live poultry will reduce the level of pathogens to a low and much safer level for human of consumption of meat. This project has received interest from major retail supermarkets where the issue of food poisoning is watched carefully. This technology applies equally to other animal groups.

Also in Australia BioAust Health is working with a major producer on control methods for Small Hive Beetles and Varroa Mites in honey production. This much needed technology will aid in the health of beehives and the increase in bee numbers in agricultural environments.

More information on our projects are in the attached documents.

BioAust can be contacted through or or by telephone

+61 (0) 4 18 888 683. Trial process and outcome reports are available to interested parties.